| Name: | Candesartan Cilexetil EP Impurity C |
| Catalogue No. | VL290017 |
| CAS No. | 1185255-99-5 |
| Molecular Formula | C33H34N6O6 |
| Molecular Weight | 610.66 |
| Status | In-stock |
| IUPAC Name | (1RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2′-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate ; |
| Synonyms | Candesartan Cilexetil N1-Ethyl Amide |
| Appearance | White Powder |
| Description | Candesartan Cilexetil EP Impurity C (CAS No: 1185255-99-5) Or (1RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2′-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate,is an impurity of Candesartan Cilexetil,Candesartan Cilexetil is a prodrug of candesartan,which is angiotensin II receptor antagonists,used in the treatment of hypertension. |
| References | Sci-Hub | The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors | 10.1161/01.str.0000075777.18006.89. (2022). Retrieved January 1, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1161/01.str.0000075777.18006.89 |
